AZD9164

DRUG3 trials

Sponsors

AstraZeneca

Conditions

Chronic Obstructive Pulmonary DiseaseHealthy

Phase 1

AZD9164 Single Ascending Dose Study in Healthy Male Subjects

CompletedNCT00847249

AstraZenecaHealthy

Start: 2009-02-28End: 2009-04-30Updated: 2009-09-23

A Single and Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Japanese Subjects

TerminatedNCT01096563

AstraZenecaHealthy

Start: 2010-03-31End: 2010-06-30Target: 27Updated: 2010-12-03

Phase 2

The Study Will Evaluate the Effect of AZD9164 in Patients With Chronic Obstructive Pulmonary Disease

CompletedNCT00939211

AstraZenecaChronic Obstructive Pulmonary Disease

Start: 2009-06-30End: 2009-11-30Updated: 2011-08-05

Related Papers

Transient paradoxical bronchospasm associated with inhalation of the LAMA AZD9164: analysis of two Phase I, randomised, double-blind, placebo-controlled studies.

2014-03-275 citations

Local and systemic effects of inhaled AZD9164 compared with tiotropium in patients with COPD.

2012-10-238 citations